胃潰瘍出血的危險因素是在最初的發作一年後的一年
Yu-Xuan Peng1, Wen-Pei Chang2,3
1Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan.
Gut pathogens
|November 28, 2024
概括
高龄,严重的,并发性疾病,以及胃或心血管疾病史增加了胃出血 (PUB) 复发的风险. 识别这些因素对于防止再接收至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 胃出血 (PUB) 是一种严重的胃肠道疾病,可能会导致危及生命的并发症.
- PUB的复发是一个重大的临床挑战,需要确定预测性风险因素.
- 了解这些风险因素对于改善患者的治疗结果和减少医疗保健负担至关重要.
研究的目的:
- 确定与胃出血 (PUB) 复发相关的独立风险因素.
- 以后期分析患者数据,以确定因一年内复发的PUB而重新入院的预测因素.
- 为PUB患者提供基于证据的临床管理和预防策略的见解.
主要方法:
- 对2020年1月1日至2022年12月31日期间入院的775名PUB患者的医疗记录进行了回顾性分析.
- 利用多变量后勤回归模型来识别因复发性PUB而导致1年再录取的独立风险因素.
- 为PUB重新入院的患者与没有重新入院的患者的相比特征.
主要成果:
- 一年PUB再入院的独立风险因素包括70岁或以上 (OR=1.62),严重的分类 (Forrest 1a-2b) (OR=2.41),以及查尔森并发症指数 (CCI) 分数为3或更高 (OR=2.25).
- 胃的病史 (OR=3.87),心血管疾病 (CVD) 的病史 (OR=2.31) 和入院国际正常化比率 (INR) > 1.2 (OR=2.14) 也是重新入院的重要预测因素.
- 相反,年龄较小,不严重,CCI得分较低,没有胃或心血管疾病史,入院INR ≤1.2与较低的再入院率有关.
结论:
- 年龄 (≥70岁),严重的分类 (Forrest 1a-2b),多种并发病 (CCI ≥3),先前的胃病史,心血管疾病史和升高的入院INR (>1.2) 是复发性PUB的确认独立风险因素.
- 这些发现强调了在预测PUB复发时考虑患者人口统计学,的严重程度,并发症负担和特定的临床标志物的重要性.
- 该研究强调,需要针对高风险PUB患者制定有针对性的监测和管理策略,以防止再接收.
相关概念视频
01:30Peptic Ulcer Disease I: Introduction
139
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
139
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
542
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
542
01:28Peptic Ulcer Disease II: Pathophysiology
285
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
285
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
01:26Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
89
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89